探索病理学家在理解 COVID-19 方面的作用:从肺炎到长期 COVID 肺部后遗症。

IF 4.4 Q1 PATHOLOGY
PATHOLOGICA Pub Date : 2023-10-01 DOI:10.32074/1591-951X-906
Gheorghe-Emilian Olteanu, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Alessandra Dubini, Fiorella Calabrese
{"title":"探索病理学家在理解 COVID-19 方面的作用:从肺炎到长期 COVID 肺部后遗症。","authors":"Gheorghe-Emilian Olteanu, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Alessandra Dubini, Fiorella Calabrese","doi":"10.32074/1591-951X-906","DOIUrl":null,"url":null,"abstract":"<p><p>The crucial role of pathologists in enhancing our understanding of SARS-CoV-2-related disease, from initial pneumonia manifestations to persistent long COVID lung symptoms, is the focus of this review. Pathological explorations have offered unprecedented insights into the early stages of severe COVID-19, shedding light on the interplay between the virus and subsequent complications, thereby shaping clinical approaches. Growing interest is directed to residual lung abnormalities of COVID-19 survivors. Although various radiological studies reported long-lasting pulmonary changes (e.g., ground glass opacities, reticulations, and bronchiectasis), the true incidence of pulmonary fibrosis and corresponding pathological findings in these patients remains largely unknown. There are a few high-impact and knowledgeable works on late complications in COVID-19 survivors, several coming from explant or autopsy cases, and rare cases from in vivo sampling. The study of biopsy samples has further deepened our knowledge of the aftermath of COVID-19 on lung tissue, uncovering alterations at the cellular level and shifts in vascular and epithelial dynamics. Despite the substantial progress made, future research is needed to devise a uniform strategy for interpreting lung biopsies, with a focus on leveraging advanced tools such as molecular and digital pathology techniques, along with artificial intelligence.</p>","PeriodicalId":45893,"journal":{"name":"PATHOLOGICA","volume":"115 5","pages":"275-283"},"PeriodicalIF":4.4000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10699331/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploring the pathologist's role in understanding COVID-19: from pneumonia to long-COVID lung sequelae.\",\"authors\":\"Gheorghe-Emilian Olteanu, Federica Pezzuto, Francesca Lunardi, Francesco Fortarezza, Alessandra Dubini, Fiorella Calabrese\",\"doi\":\"10.32074/1591-951X-906\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The crucial role of pathologists in enhancing our understanding of SARS-CoV-2-related disease, from initial pneumonia manifestations to persistent long COVID lung symptoms, is the focus of this review. Pathological explorations have offered unprecedented insights into the early stages of severe COVID-19, shedding light on the interplay between the virus and subsequent complications, thereby shaping clinical approaches. Growing interest is directed to residual lung abnormalities of COVID-19 survivors. Although various radiological studies reported long-lasting pulmonary changes (e.g., ground glass opacities, reticulations, and bronchiectasis), the true incidence of pulmonary fibrosis and corresponding pathological findings in these patients remains largely unknown. There are a few high-impact and knowledgeable works on late complications in COVID-19 survivors, several coming from explant or autopsy cases, and rare cases from in vivo sampling. The study of biopsy samples has further deepened our knowledge of the aftermath of COVID-19 on lung tissue, uncovering alterations at the cellular level and shifts in vascular and epithelial dynamics. Despite the substantial progress made, future research is needed to devise a uniform strategy for interpreting lung biopsies, with a focus on leveraging advanced tools such as molecular and digital pathology techniques, along with artificial intelligence.</p>\",\"PeriodicalId\":45893,\"journal\":{\"name\":\"PATHOLOGICA\",\"volume\":\"115 5\",\"pages\":\"275-283\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10699331/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"PATHOLOGICA\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32074/1591-951X-906\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"PATHOLOGICA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32074/1591-951X-906","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

病理学家在加深我们对 SARS-CoV-2 相关疾病(从最初的肺炎表现到持续时间较长的 COVID 肺部症状)的认识方面发挥了至关重要的作用,是本综述的重点。病理学探索为我们了解严重 COVID-19 的早期阶段提供了前所未有的视角,揭示了病毒与后续并发症之间的相互作用,从而影响了临床治疗方法。人们对 COVID-19 存活者的残留肺部异常越来越感兴趣。尽管各种放射学研究报告了长期存在的肺部变化(如磨玻璃不透明、网状结构和支气管扩张),但这些患者肺纤维化和相应病理结果的真实发生率在很大程度上仍不为人所知。关于 COVID-19 幸存者的晚期并发症,有几篇影响较大、知识渊博的文章,其中几篇来自外植体或尸检病例,还有极少数病例来自体内取样。对活检样本的研究进一步加深了我们对 COVID-19 对肺组织后遗症的了解,发现了细胞水平的改变以及血管和上皮动态的变化。尽管取得了重大进展,但未来的研究仍需制定统一的肺活检解读策略,重点是利用分子和数字病理学技术等先进工具以及人工智能。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring the pathologist's role in understanding COVID-19: from pneumonia to long-COVID lung sequelae.

The crucial role of pathologists in enhancing our understanding of SARS-CoV-2-related disease, from initial pneumonia manifestations to persistent long COVID lung symptoms, is the focus of this review. Pathological explorations have offered unprecedented insights into the early stages of severe COVID-19, shedding light on the interplay between the virus and subsequent complications, thereby shaping clinical approaches. Growing interest is directed to residual lung abnormalities of COVID-19 survivors. Although various radiological studies reported long-lasting pulmonary changes (e.g., ground glass opacities, reticulations, and bronchiectasis), the true incidence of pulmonary fibrosis and corresponding pathological findings in these patients remains largely unknown. There are a few high-impact and knowledgeable works on late complications in COVID-19 survivors, several coming from explant or autopsy cases, and rare cases from in vivo sampling. The study of biopsy samples has further deepened our knowledge of the aftermath of COVID-19 on lung tissue, uncovering alterations at the cellular level and shifts in vascular and epithelial dynamics. Despite the substantial progress made, future research is needed to devise a uniform strategy for interpreting lung biopsies, with a focus on leveraging advanced tools such as molecular and digital pathology techniques, along with artificial intelligence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
PATHOLOGICA
PATHOLOGICA PATHOLOGY-
CiteScore
5.90
自引率
5.70%
发文量
108
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信